Aryl piperazine derivatives for the treatment of neuropsychiatric disorders

摘要

Disclosed is an aryl piperazine derivative represented by Formula (I) an enantiomer thereof or a mixture of its enantiomers, or a pharmaceutically acceptable salt thereof, wherein the substituents are described in the specification. Also disclosed is the use of formula I for the manufacture of a pharmaceutical composition for the treatment, prevention or alleviation of a disease or a disorder or a condition of a mammal, including a human, which disease, disorder or condition is responsive to modulation of the dopamine and serotonin receptors.